| ISIN | CH1391066466 |
|---|---|
| Valor Number | 139106646 |
| Bloomberg Global ID | UBSSHPA SW |
| Fund Name | UBS (CH) Equity Fund - Swiss High Dividend (CHF) P-acc |
| Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
| Fund Provider | UBS Asset Management Switzerland AG, Zurich |
| Representative in Switzerland | |
| Distributor(s) |
UBS Global Asset Management Basel Phone: +41 61 288 20 20 |
| Asset Class | Equities |
| EFC Category | Equity Switzerland |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | Actively managed equity portfolio that invests in Swiss shares.|The fund is diversified across various sectors.|Investment decisions are based on a disciplined investment philosophy and careful fundamental research. |
| Peculiarities |
| Current Price * | 102.04 CHF | 03.11.2025 |
|---|---|---|
| Previous Price * | 102.18 CHF | 31.10.2025 |
| 52 Week High * | 104.78 CHF | 08.10.2025 |
| 52 Week Low * | 97.24 CHF | 23.06.2025 |
| NAV * | 102.04 CHF | 03.11.2025 |
| Issue Price * | 102.10 CHF | 03.11.2025 |
| Redemption Price * | 102.10 CHF | 03.11.2025 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 1,478,092,494 | |
| Unit/Share Assets *** | 15,799,046 | |
| Trading Information SIX | ||
| YTD Performance | - | - |
|---|---|---|
| 1 month | -1.25% |
03.10.2025 - 03.11.2025
03.10.2025 03.11.2025 |
| 3 months | +2.76% |
04.08.2025 - 03.11.2025
04.08.2025 03.11.2025 |
| 6 months | +1.37% |
10.06.2025 - 03.11.2025
10.06.2025 03.11.2025 |
| 1 year | - | - |
| 2 years | - | - |
| 3 years | - | - |
| 5 years | - | - |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Roche Holding AG | 12.72% | |
|---|---|---|
| Nestle SA | 12.72% | |
| Novartis AG Registered Shares | 10.90% | |
| UBS Group AG Registered Shares | 9.08% | |
| Zurich Insurance Group AG | 7.10% | |
| ABB Ltd | 6.75% | |
| Swiss Re AG | 5.21% | |
| Compagnie Financiere Richemont SA Class A | 4.59% | |
| Lonza Group Ltd | 3.32% | |
| Swiss Life Holding AG | 3.32% | |
| Last data update | 30.09.2025 | |
| TER | |
|---|---|
| TER date | |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.95% |
| Ongoing Charges *** | 1.50% |
|
SRRI ***
|
|
| SRRI date *** | 30.09.2025 |